Sun Pharmaceutical Industries Shows Stability Amid Mixed Short-Term Trends in Pharma Sector
Sun Pharmaceutical Industries has demonstrated stability in the pharmaceuticals sector, trading consistently at Rs 1,757.2. The company, with a market capitalization of Rs 4,18,971.87 crore, has a P/E ratio of 35.67. Over the past year, it has outperformed the Sensex, despite a year-to-date decline.
Sun Pharmaceutical Industries has shown notable activity in the pharmaceuticals and drugs sector today, maintaining performance in line with the broader market. The stock has experienced a consecutive gain over the last two days, rising by 0.64%. It opened at Rs 1,757.2 and has traded at this price throughout the day, indicating stability in its trading range.In terms of moving averages, Sun Pharmaceutical's current price is above the 5-day, 20-day, 50-day, and 100-day moving averages, yet remains below the 200-day moving average, suggesting a mixed short- to medium-term trend.
The company holds a market capitalization of Rs 4,18,971.87 crore, categorizing it as a large-cap stock. Its price-to-earnings (P/E) ratio stands at 35.67, closely aligning with the industry average of 35.68.
Over the past year, Sun Pharmaceutical Industries has delivered a return of 17.69%, significantly outperforming the Sensex, which recorded an 8.62% increase. However, year-to-date performance shows a decline of 7.34%, contrasting with the Sensex's gain of 2.50%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
